Nephropathy correlates at baseline in the veterans affairs diabetes trial (VADT)

被引：0
|
作者：
Emanuele, N.
Moritz, T.
Azad, N.
Agrawal, L.
Duckworth, W.
Abraira, C.
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A216 / A216
页数：1
相关论文
共 50 条
  • [21] Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT)
    Saremi, Aramesh
    Anderson, Robert J.
    Luo, Ping
    Moritz, Thomas E.
    Schwenke, Dawn C.
    Allison, Mathew
    Reaven, Peter D.
    [J]. ATHEROSCLEROSIS, 2009, 203 (02) : 610 - 614
  • [22] Rates and Determinants of Coronary and Abdominal Aortic Artery Calcium Progression in the Veterans Affairs Diabetes Trial (VADT)
    Saremi, Aramesh
    Moritz, Thomas E.
    Anderson, Robert J.
    Abraira, Carlos
    Duckworth, William C.
    Reaven, Peter D.
    [J]. DIABETES CARE, 2010, 33 (12) : 2642 - 2647
  • [23] Association of blood glucose control and pancreatic reserve with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT)
    Azad, Nasrin
    Agrawal, Lily
    Emanuele, Nicholas V.
    Klein, Ronald
    Bahn, Gideon D.
    Reaven, Peter
    [J]. DIABETOLOGIA, 2014, 57 (06) : 1124 - 1131
  • [24] Proliferative diabetic retinopathy is strongly related to coronary artery calcium in the veterans affairs diabetes trial (VADT)
    Reaven, Peter D.
    Moritz, Tom
    Emanuele, Nicholas
    Klein, Ronald
    Duckworth, William
    Abraira, Carlos
    [J]. DIABETES, 2007, 56 : A70 - A70
  • [25] Proliferative diabetic retinopathy in type 2 diabetes is related to coronary artery calcium in the Veterans Affairs Diabetes Trial (VADT)
    Reaven, Peter D.
    Emanuele, Nicholas
    Moritz, Thomas
    Klein, Ronald
    Davis, Mathew
    Glander, Kathy
    Duckworth, William
    Abraira, Carlos
    [J]. DIABETES CARE, 2008, 31 (05) : 952 - 957
  • [26] The Effect of Intensive Glucose Lowering on Lipoprotein Particle Profiles and Inflammatory Markers in the Veterans Affairs Diabetes Trial (VADT)
    Koska, Juraj
    Saremi, Aramesh
    Bahn, Gideon
    Yamashita, Shizuya
    Reaven, Peter D.
    [J]. DIABETES CARE, 2013, 36 (08) : 2408 - 2414
  • [27] Levels of Connective Tissue Growth Factor (CTGF) Predict Myocardial Infarction in the Veterans Affairs Diabetes Trial (VADT) Study
    Hunt, Kelly J.
    Jaffa, Miran A.
    Luttrell, Deirdre K.
    Garrett, Sara M.
    Lipson, Kenneth
    Lin, Yin
    Lopes-Virella, Maria F.
    Luttrell, Lous M.
    Jaffa, Ayad A.
    [J]. DIABETES, 2017, 66 : A1 - A1
  • [28] Intensive Glucose Lowering in the Veterans Affairs Diabetes Trial (VADT) Does Not Lower Inflammatory Factors That Are Associated with Macrovascular Events
    Koska, Juraj
    Saremi, Aramesh
    Moritz, Thomas E.
    Abraira, Carlos
    Duckworth, William
    Reaven, Peter D.
    [J]. DIABETES, 2010, 59 : A223 - A224
  • [29] Cardiovascular events and correlates in the Veterans Affairs diabetes feasibility trial - Veterans Affairs Cooperative Study on gylcemic control and complications in type II diabetes
    Abraira, C
    Colwell, J
    Nuttall, F
    Sawin, CT
    Henderson, W
    Comstock, JP
    Emanuele, NV
    Levin, SR
    Pacold, I
    Lee, HS
    Silbert, CK
    Cxypoliski, R
    Vasquez, M
    Kernan, D
    Niewoehner, C
    Backes, M
    Bradley, M
    Bradley, M
    Crow, R
    Rubino, F
    Bushnell, D
    Pfeifer, M
    Service, FJ
    Howard, B
    Chew, E
    Hoogwerf, B
    Seigel, D
    Clark, CM
    Olefsky, JM
    Porte, D
    Sussman, KE
    Johnson, N
    Christine, B
    Tir, K
    Sather, M
    Day, P
    Morgan, N
    Deykin, D
    Gold, J
    Huang, P
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (02) : 181 - 188
  • [30] Intensive Glycemic Control Improves Long-term Renal Outcomes in Type 2 Diabetes in the Veterans Affairs Diabetes Trial (VADT)
    Agrawal, Lily
    Azad, Nasrin
    Bahn, Gideon D.
    Reaven, Peter D.
    Hayward, Rodney A.
    Reda, Domenic J.
    Emanuele, Nicholas V.
    [J]. DIABETES CARE, 2019, 42 (11) : E181 - E182
12345